Only a small amount of Th17-associated cytokine exposure could remarkably facilitate cancer progression (Lee et al., 2012), while some studies support that a high level of IL-17 would result in an anti-tumor immune status (Numasaki et al., 2005). The gene discussed is IL17A; the disease is neoplasm.